Structure Database (LMSD)

LM_ID Common Name Systematic Name Main class Sub class Mass Formula
LMSP0502AI02 type IV H(d18:1/18:0) Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1562.89 C74H134N2O32
LMSP0502AI03 type IV H(d18:1/20:0) Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1590.92 C76H138N2O32
LMSP0502AI04 type IV H(d18:1/22:0) Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1618.95 C78H142N2O32
LMSP0502AI05 type IV H(d18:1/24:0) Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1646.99 C80H146N2O32
LMSP0502AI07 type IV H(d18:1/24:1(15Z)) Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1644.97 C80H144N2O32
LMSP0502AI06 type IV H(d18:1/26:0) Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1675.02 C82H150N2O32
LMSP0502AI08 type IV H(d18:1/26:1(17Z)) Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1673 C82H148N2O32
LMSP0502BK05 Galbeta1-3GalNAcbeta1-4Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1500.93 C74H136N2O28
LMSP0502BN05 GalNAcbeta1-3(Fucalpha2-3Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1850.07 C88H159N3O37
LMSP0502BN06 GalNAcbeta1-3(Fucalpha2-3Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1878.1 C90H163N3O37
LMSP0502BN07 GalNAcbeta1-3(Fucalpha2-3Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1848.05 C88H157N3O37
LMSP0502AY03 Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1890 C86H155NO43
LMSP0502AQ08 GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1689 C82H148N2O33
LMSP0502BB03 GalNAcalpha1-3GalNAcbeta1-3(GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1688.97 C80H144N4O33
LMSP0502AZ08 GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 2175.15 C100H178N2O48
LMSP0502AG08 Galbeta1-3(Galbeta1-4GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1892.08 C90H161N3O38
LMSP0502BF01 Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1550.86 C72H130N2O33
LMSP0502AZ01 GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 2037.01 C90H160N2O48
LMSP0502BJ06 Galbeta1-3(Fucalpha2-3GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1878.1 C90H163N3O37
LMSP0502BA05 Galalpha1-4GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1500.93 C74H136N2O28
LMSP0502AV03 GalNAcalpha1-3GalNAcbeta1-3(Fucalpha1-2Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1997.08 C92H164N4O42
LMSP0502AR05 GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1825.03 C86H156N2O38
LMSP0502AV05 GalNAcalpha1-3GalNAcbeta1-3(Fucalpha1-2Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 2053.14 C96H172N4O42
LMSP0502AR01 GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1712.91 C78H140N2O38
LMSP0502AW01 Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1671.88 C76H137NO38
LMSP0502BF03 Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1606.92 C76H138N2O33
LMSP0502AO08 Galbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1323.86 C68H125NO23
LMSP0502BF04 Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1634.95 C78H142N2O33
LMSP0502BF06 Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1691.01 C82H150N2O33
LMSP0502AS02 GlcNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1254.78 C62H114N2O23
LMSP0502BA03 Galalpha1-4GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1444.87 C70H128N2O28
LMSP0502BN08 GalNAcbeta1-3(Fucalpha2-3Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1876.08 C90H161N3O37
LMSP0502AX07 GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1985.07 C92H164N2O43
LMSP0502BA01 Galalpha1-4GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1388.8 C66H120N2O28
LMSP0502AQ05 GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1662.98 C80H146N2O33
LMSP0502AO06 Galbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1325.88 C68H127NO23
LMSP0502AL01 Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1185.72 C58H107NO23
LMSP0502AG04 Galbeta1-3(Galbeta1-4GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1838.03 C86H155N3O38
LMSP0502BC07 GalNAcbeta1-3(GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1539.94 C76H137N3O28
LMSP0502AG05 Galbeta1-3(Galbeta1-4GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1866.06 C88H159N3O38
LMSP0502BN02 GalNAcbeta1-3(Fucalpha2-3Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1765.97 C82H147N3O37
LMSP0502BD05 GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1541.95 C76H139N3O28
LMSP0502AV01 GalNAcalpha1-3GalNAcbeta1-3(Fucalpha1-2Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1941.02 C88H156N4O42
LMSP0502AU01 Fucalpha1-2Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1331.78 C64H117NO27
LMSP0502BG04 Galbeta1-4GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1675.98 C80H145N3O33
LMSP0502AV02 GalNAcalpha1-3GalNAcbeta1-3(Fucalpha1-2Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1969.05 C90H160N4O42
LMSP0502AN04 Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1593.92 C76H139NO33
LMSP0502AV06 GalNAcalpha1-3GalNAcbeta1-3(Fucalpha1-2Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 2081.18 C98H176N4O42
LMSP0502AV07 GalNAcalpha1-3GalNAcbeta1-3(Fucalpha1-2Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 2051.13 C96H170N4O42
LMSP0502AV08 GalNAcalpha1-3GalNAcbeta1-3(Fucalpha1-2Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 2079.16 C98H174N4O42